Service d'anatomie pathologique, centre François-Baclesse, 3, avenue du Général-Harris, 14000 Caen, France; Service d'anatomie pathologique, centre hospitalier Public du Cotentin, 46, rue du Val-de-Saire, 50100 Cherbourg-Octeville, France.
Published: August 2016
AI Article Synopsis
Article Abstract
We report a case of vaginal adenosis in a woman of 42years. This is a rare congenital disorder since cessation of use of diethylstilbestrol (DES), usually of benign course, not to ignore in its tubo-endometrial histological form which may progress to atypical adenosis precursor of vaginal clear cell adenocarcinoma in patients exposed in utero to DES.
Objective: The objective of this video is to review a case of a patient that presented to urogynecology clinic for prolapse but was noted to have anterior vaginal cyst. In this video, we review differential diagnosis, embryologic origin of vaginal cyst, excision procedure, imaging, and pathology of the vaginal cyst.
Setting: Urogynecology clinic/operating room PARTICIPANT: Patient who presented with anterior vaginal cyst INTERVENTION: Thirty-four-year-old G0 referred to Urogynecology for a vaginal bulge.
In the last two decades or so, a spectrum of benign, premalignant and malignant cervical glandular lesions exhibiting gastric differentiation has been described, with gastric-type adenocarcinoma representing the most common human papillomavirus (HPV)-independent cervical adenocarcinoma. More recently, limited literature has reported a variety of gastric-type glandular lesions at other sites within the female genital tract and, as in the cervix (the most common site for these lesions), a spectrum of benign, premalignant and malignant lesions has been proposed. We provide an update and review of the emerging spectrum of gastric-type glandular lesions at female genital tract sites other than the cervix.
Department of Pathology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Unlabelled: Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are severe mucocutaneous hypersensitivity disorders characterized by sudden onset epidermal necrosis. Acute manifestations of SJS/TEN often include vulvovaginal erosions, ulcerations, vaginal discharge, bleeding, vaginal pain, dysuria, and urinary retention. If not treated, this can lead to complications such as vulvovaginal adhesions, vaginal stenosis or dryness, pain, dyspareunia, bleeding, and adenosis.
Stevens-Johnson syndrome is a rare, life-threatening mucocutaneous condition causing necrosis and detachment of the epidermis. Vulvovaginal involvement, seen in up to 70% of affected women, can lead to painful chronic conditions such as adenosis, hematocolpos, and chronic pelvic pain. To date, there is no consensus regarding the optimal treatment of vulvovaginal involvement.
